The Tetra

What The Tetra does

The Tetra Corporation is a privately held, US-based specialty pharmaceutical and cosmeceutical manufacturer headquartered in Eaton Rapids, Michigan, operating an FDA registered laboratory where it formulates and produces a portfolio of topical antifungals, dermatologic treatments, and dietary supplements. The company's foundation is a patented process, invented by founder Paul J. DiMeglio Ph.D. and granted as a registered patent, that makes tolnaftate soluble in jojoba oil. This formulation architecture underpins the core product family, including Formula 3, Formula 7, Rapid MicroGel, and FungiFoam, and is positioned by the company as unique among all global tolnaftate products, which exist in suspension form. The portfolio also extends to wart treatment (GlyCylic), hyperhidrosis control (NeverWet), antimicrobial shoe protection (Clean Sweep), keratolytic skincare (Kamea 20, Kamea G), moisturization (Joba Silk), nail care (Myrrhage), and ingestible supplements for diabetic peripheral neuropathy, joint health, and beauty support (Alaplex, CoLig-10, Triova). All products are fragrance-free, dye-free, USP Grade, and manufactured in the USA; Formula 3 carries the American Podiatric Medical Association Seal of Approval.

The company operates an exclusive, in-office physician-dispensing go-to-market model. All products are sold only through medical offices staffed by DEA-licensed healthcare professionals, primarily podiatrists and dermatologists; the company does not sell online, in retail, or in pharmacies. Distribution is supported by a dedicated Physicians Portal, in-person Lunch & Learn training programs that have produced material per-office sales uplift, Regional Sales Manager coverage, a Find a Doctor tool for patient acquisition, and content marketing (seasonal newsletters, blog articles, physician testimonial videos, and social media). End customers are individual prescribing physicians and the patients they treat, with revenue mechanics centered on one-time product sales through dispensing accounts rather than subscription or enterprise contracts. The company has been operating for more than 30 years, was restructured in 2008 to focus exclusively on the physician channel, and is led as a founder-controlled private entity with no disclosed institutional investors, subsidiaries, M&A, or international operations.

Name

The Tetra

Legal name

The Tetra Corporation

Website

https://thetetracorp.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

101–250 employees

Short description

The Tetra Corporation is a privately held US specialty pharmaceutical manufacturer that produces topical antifungals, dermatologic treatments, and supplements based on a patented soluble tolnaftate-in-jojoba-oil process, selling exclusively through podiatrists and dermatologists via in-office dispensing.

Ownership category

akta.pro rank

Product category

Topical pharmaceuticals (podiatric and dermatological)

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro industry

PRIMARYCRADAMAF

Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

SECONDARYCRADANAK

Foot Care (Deodorizing, Anti-chafe, Callus Care)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Consumer Fragrances & Personal Care Manufacturing (Non-cosmetic)

SECONDARYCRABAAAF

Dermocosmetics & Medical-Grade Skincare

Consumer Products & Retail/Beauty & Personal Care/Skincare

SECONDARYHLAIABAE

Topical & Dermatology Generics

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

Keywords

• Topical antifungal formulations
• Physician-dispensed podiatry products
• Dermatology skincare treatments
• Jojoba-oil pharmaceutical base
• Pharmaceutical manufacturing Michigan

Headquarters

HQ city

Eaton Rapids

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Product Sales through Medical Offices: Revenue is generated through the sale of healthcare products dispensed exclusively through licensed medical providers (podiatrists and dermatologists). Products are one-time purchase OTC medications. The company does not sell directly to consumers, pharmacies, or online.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels8 records

Core offering

The Tetra Corporation develops, manufactures, and distributes topical pharmaceutical products—including antifungal, keratolytic, anti-perspirant, antimicrobial, and skincare formulations—built around a proprietary jojoba-oil-soluble tolnaftate base technology, along with a small line of physician-dispensed dietary supplements. Products are produced in its FDA-registered laboratory in Eaton Rapids, Michigan and sold exclusively through licensed medical professionals (podiatrists and dermatologists) who dispense them to patients.

Product overview

The Tetra Corporation offers a portfolio of dermatological and podiatric products dispensed exclusively through licensed medical providers. The portfolio centers on antifungal treatments (Formula 3®, Formula 7®, Rapid MicroGel®, FungiFoam®) built on the company's patented soluble tolnaftate technology. Supporting products include foot care solutions (Clean Sweep® for odor, NeverWet® for hyperhidrosis, Kamea® 20 and Kamea® G for skin conditions), nail treatments (Myrrhage®), wart removal (GlyCylic®), and dietary supplements for nerve health (Alaplex™), joint health (CoLig-10™), and beauty support (Triova™). All products are fragrance- and dye-free, use USP Grade ingredients, and are never tested on animals.

Differentiator

Problem solved

Functional benefit

Brands

• GlyCylic®: Professional strength spray for wart removal
• ALAPLEX™
• Formula 7®
• Formula 3®
• Rapid MicroGel®
• Clean Sweep®
• CoLig-10™
• FungiFoam®
• Kamea® 20
• Kamea® G
• Joba Silk®
• NeverWet®
• Myrrhage®
• Triova™

Products and services

• Formula 3® Antifungal Topical antifungal solution built on the company's proprietary jojoba-oil-soluble tolnaftate base, indicated for the treatment of fungal infections of the skin and nails, dispensed through licensed podiatrists and dermatologists.
• Formula 7® Solution Topical tolnaftate-based antifungal solution formulated in the company's jojoba-oil base, marketed alongside Formula 3 as a physician-dispensed option for skin and nail fungal conditions.
• Rapid MicroGel® Antifungal New gel-based topical antifungal product launched by The Tetra in January 2025, extending the company's tolnaftate antifungal franchise into a gel dosage form for physician dispensing.
• FungiFoam® Foam-format topical antifungal preparation using the company's tolnaftate-in-jojoba-oil base, designed for podiatric and dermatological use.
• GlyCylic® Glycolic-acid-based topical keratolytic preparation used in podiatric and dermatological practices for wart removal and hyperkeratotic skin conditions.
• Alaplex™ Dietary supplement formulated to support nerve health, distributed through licensed physicians for patient use.
• CoLig-10™ Dietary supplement positioned to support joint health, sold through licensed physicians as an adjunct to topical therapies.
• Triova™ Dietary supplement formulated to support beauty/skin health from within, sold through licensed physicians.
• Clean Sweep® Antimicrobial topical spray designed to eliminate odor-causing bacteria and fungi from footwear, supporting podiatric treatment of foot odor and onychomycosis.
• Kamea® 20 20% urea-based intensive topical moisturizer for dry and calloused skin, dispensed by podiatrists and dermatologists.
• Kamea® G Glycolic-acid-based topical preparation for callused, thickened skin and keratolytic treatment, dispensed through licensed physicians.
• Joba Silk® Jo joba-oil-based topical moisturizer used as a daily-use adjunctive skincare product dispensed through physician offices.
• NeverWet® Topical anti-perspirant treatment for hyperhidrosis (excessive sweating) of feet and hands, dispensed through podiatry and dermatology practices.
• Myrrhage® Myrrh-based topical treatment formulated in jojoba-oil base for damaged, fungal, and dystrophic nails, dispensed by podiatrists and dermatologists.

Quantifiable outcome

• Some offices experienced nearly 700% increase in annual sales after Lunch & Learn sessions
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• PediFix Footcare: PediFix sells professional foot care and podiatric products through podiatrists and medical offices. It is the most direct analogue to Tetra's DPM-focused, in-office dispensing model across foot/skin care categories.
• Bako Health (Bako Diagnostics): Bako develops and distributes podiatry-focused diagnostic and therapeutic products sold through podiatric physicians. Same narrow specialty channel (DPMs) and analogous go-to-market via physician dispensing.
• Medimetriks Pharmaceuticals: Medimetriks is a U.S. specialty pharma focused on prescription dermatology products sold through dermatologists. Same specialty-channel physician-dispensing model targeting dermatologists.

Broad incumbents

• Bayer Consumer Health (Lotrimin, Tinactin): Bayer's Consumer Health division owns the dominant OTC antifungal brands (Lotrimin, Tinactin) sold across mass retail and pharmacy. Competes with Tetra's core tolnaftate franchise but at much larger scale via retail distribution.
• Galderma: Galderma is a global dermatology-focused pharmaceutical and skincare company with prescription and OTC products sold through dermatologists and pharmacies. Overlaps with Tetra in dermatology physician channels at vastly larger scale.
• Dr. Scholl's (Bayer): Dr. Scholl's is the leading consumer foot care brand (insoles, antifungal sprays, callus treatments) sold in mass retail. Comparable product categories (antifungal, foot care, callus) but opposite distribution strategy — retail vs. physician-only.
• Church & Dwight (Arm & Hammer foot care): Church & Dwight markets OTC foot care and antifungal products (e.g., OxiClean foot, Arm & Hammer foot care line) in mass retail. Comparable end-product category but vastly larger scale and different distribution.
• Bausch Health / Ortho Dermatologics: Bausch Health's Ortho Dermatologics unit sells prescription dermatology products (acne, actinic keratosis, etc.) through dermatology offices. Comparable dermatology-channel dispensing model but at much broader therapeutic and geographic scope.
• Valeant / Bausch + Lomb Consumer: Bausch + Lomb and historical Valeant portfolio include OTC dermatology/skincare lines sold through pharmacies and physician offices. Comparable category footprint (topical dermatology, OTC) but at much larger scale and broader retail-pharmacy distribution.

Emerging players

• Dermavant Sciences: Dermavant is a clinical-stage dermatology biopharma developing topical therapies for skin conditions (psoriasis, atopic dermatitis). Adjacent in dermatology physician channels and topical formulations, but prescription biotech rather than OTC topical consumer product.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/TheTetraCorp
• YouTubeyoutube.com/user/TheTetraCorporation
• Facebookfacebook.com/people/The-Tetra-Corporation/100063566170012
• Instagraminstagram.com/thetetracorp

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Tetra